华海药业跌停，机构龙虎榜净卖出4665.26万元

Core Viewpoint - Huahai Pharmaceutical (600521) experienced a significant drop in stock price, reaching the daily limit down, with a trading volume of 22.27 billion yuan and a turnover rate of 5.97% [2] Trading Activity - The stock saw a net institutional sell-off of 46.65 million yuan, while the Shanghai-Hong Kong Stock Connect recorded a net buy of 45.52 million yuan [2] - The top five trading departments accounted for a total transaction of 637 million yuan, with a net sell of 53.10 million yuan [2] - The main buying department was the Shanghai-Hong Kong Stock Connect, with a buy amount of 149.14 million yuan and a sell amount of 103.62 million yuan [3][4] Fund Flow - The stock experienced a net outflow of 423 million yuan in main funds, with a large single net outflow of 376 million yuan and a net outflow of 46.57 million yuan from large orders [2] - Over the past five days, the main funds have seen a net outflow of 320 million yuan [2] Margin Trading Data - As of September 8, the stock's margin trading balance was 1.05 billion yuan, with a financing balance of 1.03 billion yuan and a securities lending balance of 17.19 million yuan [3] - The financing balance increased by 121 million yuan over the past five days, representing a growth of 13.19%, while the securities lending balance rose by 340.49 million yuan, a growth of 24.71% [3] Financial Performance - For the first half of the year, the company reported a revenue of 4.52 billion yuan, a year-on-year decrease of 11.93%, and a net profit of 409 million yuan, down 45.30% year-on-year [3]